IBDEI1HJ ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26649,2)
 ;;=^275214
 ;;^UTILITY(U,$J,358.3,26650,0)
 ;;=907.0^^158^1630^3
 ;;^UTILITY(U,$J,358.3,26650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26650,1,3,0)
 ;;=3^Late Effect w/o Skull Fx
 ;;^UTILITY(U,$J,358.3,26650,1,4,0)
 ;;=4^907.0
 ;;^UTILITY(U,$J,358.3,26650,2)
 ;;=^68489
 ;;^UTILITY(U,$J,358.3,26651,0)
 ;;=V15.52^^158^1630^1
 ;;^UTILITY(U,$J,358.3,26651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26651,1,3,0)
 ;;=3^Personal Hx of TBI
 ;;^UTILITY(U,$J,358.3,26651,1,4,0)
 ;;=4^V15.52
 ;;^UTILITY(U,$J,358.3,26651,2)
 ;;=^338495
 ;;^UTILITY(U,$J,358.3,26652,0)
 ;;=V15.59^^158^1631^1
 ;;^UTILITY(U,$J,358.3,26652,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26652,1,3,0)
 ;;=3^Personal Hx of Injury
 ;;^UTILITY(U,$J,358.3,26652,1,4,0)
 ;;=4^V15.59
 ;;^UTILITY(U,$J,358.3,26652,2)
 ;;=^336787
 ;;^UTILITY(U,$J,358.3,26653,0)
 ;;=413.9^^158^1632^1
 ;;^UTILITY(U,$J,358.3,26653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26653,1,3,0)
 ;;=3^Angina Pectoris NEC/NOS
 ;;^UTILITY(U,$J,358.3,26653,1,4,0)
 ;;=4^413.9
 ;;^UTILITY(U,$J,358.3,26653,2)
 ;;=^87258
 ;;^UTILITY(U,$J,358.3,26654,0)
 ;;=716.90^^158^1632^2
 ;;^UTILITY(U,$J,358.3,26654,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26654,1,3,0)
 ;;=3^Arthropathy NOS
 ;;^UTILITY(U,$J,358.3,26654,1,4,0)
 ;;=4^716.90
 ;;^UTILITY(U,$J,358.3,26654,2)
 ;;=^66343
 ;;^UTILITY(U,$J,358.3,26655,0)
 ;;=428.0^^158^1632^3
 ;;^UTILITY(U,$J,358.3,26655,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26655,1,3,0)
 ;;=3^CHF,Unspec
 ;;^UTILITY(U,$J,358.3,26655,1,4,0)
 ;;=4^428.0
 ;;^UTILITY(U,$J,358.3,26655,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,26656,0)
 ;;=585.9^^158^1632^4
 ;;^UTILITY(U,$J,358.3,26656,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26656,1,3,0)
 ;;=3^Chr Kidney Disease NOS
 ;;^UTILITY(U,$J,358.3,26656,1,4,0)
 ;;=4^585.9
 ;;^UTILITY(U,$J,358.3,26656,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,26657,0)
 ;;=585.1^^158^1632^5
 ;;^UTILITY(U,$J,358.3,26657,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26657,1,3,0)
 ;;=3^Chr Kidney Disease,Stage I
 ;;^UTILITY(U,$J,358.3,26657,1,4,0)
 ;;=4^585.1
 ;;^UTILITY(U,$J,358.3,26657,2)
 ;;=^332807
 ;;^UTILITY(U,$J,358.3,26658,0)
 ;;=585.2^^158^1632^6
 ;;^UTILITY(U,$J,358.3,26658,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26658,1,3,0)
 ;;=3^Chr Kidney Disease,Stage II
 ;;^UTILITY(U,$J,358.3,26658,1,4,0)
 ;;=4^585.2
 ;;^UTILITY(U,$J,358.3,26658,2)
 ;;=^332808
 ;;^UTILITY(U,$J,358.3,26659,0)
 ;;=585.3^^158^1632^7
 ;;^UTILITY(U,$J,358.3,26659,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26659,1,3,0)
 ;;=3^Chr Kidney Disease,Stage III
 ;;^UTILITY(U,$J,358.3,26659,1,4,0)
 ;;=4^585.3
 ;;^UTILITY(U,$J,358.3,26659,2)
 ;;=^332809
 ;;^UTILITY(U,$J,358.3,26660,0)
 ;;=585.4^^158^1632^8
 ;;^UTILITY(U,$J,358.3,26660,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26660,1,3,0)
 ;;=3^Chr Kidney Disease,Stage IV
 ;;^UTILITY(U,$J,358.3,26660,1,4,0)
 ;;=4^585.4
 ;;^UTILITY(U,$J,358.3,26660,2)
 ;;=^332810
 ;;^UTILITY(U,$J,358.3,26661,0)
 ;;=585.5^^158^1632^9
 ;;^UTILITY(U,$J,358.3,26661,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26661,1,3,0)
 ;;=3^Chr Kidney Disease,Stage V
 ;;^UTILITY(U,$J,358.3,26661,1,4,0)
 ;;=4^585.5
 ;;^UTILITY(U,$J,358.3,26661,2)
 ;;=^332811
 ;;^UTILITY(U,$J,358.3,26662,0)
 ;;=585.6^^158^1632^11
 ;;^UTILITY(U,$J,358.3,26662,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26662,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,26662,1,4,0)
 ;;=4^585.6
 ;;^UTILITY(U,$J,358.3,26662,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,26663,0)
 ;;=401.9^^158^1632^12
 ;;^UTILITY(U,$J,358.3,26663,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26663,1,3,0)
 ;;=3^Hypertension
